prescription drugs

Private payers, including Blue Cross Blue Shield of Tennessee, were bilked out of about $174 million in the compounding pharmacy...

The HHS secretary called PhRMA's voluntary action 'a small step in the right direction' but vowed to carry the Trump...

The president was expected to sign two bills Wednesday that ban clauses that prohibit pharmacists from telling customers when they...

A new set of guidelines features recommendations for nearly a dozen focal points where medication errors can be avoided in...

Stakeholders call the 340B program 'a tremendous success' as Congress considers legislation that would raise the eligibility threshold and cut...

Advocates for importation of cheaper drugs raised a red flag, noting that policies are not permanent and could be changed...

The arrangement aims to advance, and is contingent upon, regulatory review of the CVS-Aetna merger.

Massachusetts wanted to negotiate prices for about 1% of the highest-priced drugs and stop covering some of them. CMS rejected...

Post-recession spending growth is climbing towards pre-recession levels and is largely driven by brand-name drugs, ER visits, and outpatient surgeries.

A ProPublica analysis found that black people and Native Americans are under-represented in clinical trials of new drugs, even when...

Starting next year, Medicare Advantage plans will be able to add restrictions on expensive, injectable drugs administered by doctors to...

The plaintiffs want a judge to order HHS to make 2017 340B regulations effective within 30 days.